Medication acquisition and self-reported adherence in veterans with hypertension

Medical Care

Volumn 47, Issue 4, 2009, Pages 474-481

  Thorpe, Carolyn T ^a,f   Bryson, Chris L ^b,c   Maciejewski, Matthew L ^d,e   Bosworth, Hayden B ^b,d,e  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d DURHAM VA MEDICAL CENTER   (United States)

^e Department of Psychiatry and Behavioral Sciences ^*

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertension; Medication acquisition; Refill adherence; Self report

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

ADULT; ARTICLE; BEHAVIOR; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; DRUG UTILIZATION; EMPLOYMENT STATUS; HEALTH CARE DELIVERY; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL RECORD; PATIENT COMPLIANCE; SELF REPORT; SOCIAL PSYCHOLOGY; UNSPECIFIED SIDE EFFECT; VETERAN; AGED; ALGORITHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; PRESCRIPTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STATISTICS; UNITED STATES;

AGED; ALGORITHMS; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NORTH CAROLINA; PATIENT COMPLIANCE; PRESCRIPTIONS; QUESTIONNAIRES; VETERANS;

EID: 64249155676     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31818e7d4d     Document Type: Article

References (48)

1. Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44: 398-404.
2. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.
3. Krousel-Wood M, Thomas S, Muntner P, et al. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19:357-362.
4. Park J, Campese V. Clinical characteristics of resistant hypertension: the importance of compliance and the role of diagnostic evaluation in delineating pathogenesis. J Clin Hypertens (Greenwich). 2007;9:7-12.
5. Munger MA, Van Tassell BW, LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor. MedGenMed. 2007;9:58.
6. DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794-811.
7. Esposti LD, Di Martino M, Saragoni S, et al. Pharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapies. J Clin Hypertens (Greenwich). 2004;6:76-84.
8. Degli Esposti L, Degli Esposti E, Valpiani G, et al. A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther. 2002;24:1347-1357; discussion 1346.
9. Juncos LI. Patient compliance and angiotensin converting enzyme inhibitors in hypertension. J Cardiovasc Pharmacol. 1990;15(Suppl 3): S22-S25.
10. Degli Esposti E, Sturani A, Di Martino M, et al. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens. 2002; 16:439-444.
11. Clark LT. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J. 1991; 121:664- 669.
12. Schlenk EA, Dunbar-Jacob J, Engberg S. Medication non-adherence among older adults: a review of strategies and interventions for improvement. J Gerontol Nurs. 2004;30:33-43.
13. Luscher TF, Vetter W. Adherence to medication. J Hum Hypertens. 1990;4(Suppl l):43-46.
14. Lowry KP, Dudley TK, Oddone EZ, et al. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother. 2005; 39:1198-1203.
15. Bosworth HB. Medication treatment adherence. In: Bosworth HB, Oddone EZ, Weinberger M, eds. Patient Treatment Adherence: Concepts, Interventions, and Measurement. Mahwah, NJ: Lawrence Erlbaum Associates; 2006:147-194.
16. Bosworth HB, Olsen MK, Oddone EZ. Improving blood pressure control by tailored feedback to patients and clinicians. Am Heart J. 2005;149: 795-803.
17. Bosworth HB, Oddone EZ. A model of psychosocial and cultural antecedents of blood pressure control. J Natl Med Assoc. 2002;94:236-248.
18. Ickovics JR, Meisler AW. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol. 1997;50: 385-391.
19. WHO. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.
20. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19:1190-1196.
21. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S79-S87.
22. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846-857.
23. Wetzels GE, Nelemans PJ, Schouten JS, et al. All that glisters is not gold: a comparison of electronic monitoring versus filled prescriptions-an observational study. BMC Health Serv Res. 2006;6:8.
24. Morris AB, Li J, Kroenke K, et al. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 2006;26:483-492.
25. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105-116.
26. Cook CL, Wade WE, Martin BC, et al. Concordance among three self-reported measures of medication adherence and pharmacy refill records. J Am Pharm Assoc (Washington DC). 2005;45:151-159.
27. Bryson CL, Au DH, Young B, et al. A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care. 2007;45:497-504.
28. Stroupe KT, Teal EY, Weiner M, et al. Health care and medication costs and use among older adults with heart failure. Am J Med. 2004; 116: 443-450.
29. Stroupe KT, Teal EY, Tu W, et al. Association of refill adherence and health care use among adults with hypertension in an urban health care system. Pharmacotherapy. 2006;26:779-789.
30. Stroupe KT, Murray MD, Stump TE, et al. Association between medication supplies and healthcare costs in older adults from an urban healthcare system. J Am Geriatr Soc. 2000;48:760-768.
31. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med. 2007;120:26-32.
32. Gazmararian JA, Kripalani S, Miller MJ, et al. Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med. 2006;21:1215-1221.
33. Yang M, Barner JC, Worchel J. Factors related to antipsychotic oversupply among Central Texas Veterans. Clin Ther. 2007;29:1214-1225.
34. Bosworth HB, Olsen MK, Goldstein MK, et al. The veterans' study to improve the control of hypertension (V-STITCH): design and methodology. Contemp Clin Trials. 2005;26:155-168.
35. Avom J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279:1458-1462.
36. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
37. Erickson SR, Coombs JH, Kirking DM, et al. Compliance from selfreported versus pharmacy claims data with metered-dose inhalers. Ann Pharmacother. 2001;35:997-1003.
38. JNC. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-2446.
39. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
40. Jette AM, Cummings KM, Brock BM, et al. The structure and reliability of health belief indices. Health Serv Res. 1981;16:81-98.
41. Bosworth HB, Hoff J, Box T, et al. Patient factors related to poor blood pressure control. The 19th Annual Health Service Research and Development Meetings. Washington, DC; 2001.
42. Catz SL, Kelly JA, Bogart LM, et al. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19:124-133.
43. Davis TC, Long SW, Jackson RH, et al. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med. 1993;25:391~395.
44. Williams RB, Barefoot JC, Califf RM, et al. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA. 1992;267:520-524.
45. Kazis LE, Wilson N, Skinner K, et al. Health status and outcomes of veterans: Physical and mental component summary scores (Veterans SF-12). 1998 National Survey of Hospitalized Patients, Executive Report. Washington, DC and Bedford, MA: Office of Performance and Quality and Health Assessment Project, Health Services Research and Development Service; 1999.
46. Jones D, Kazis L, Lee A, et al. Health status assessments using the Veterans SF-12 and SF-36: methods for evaluating outcomes in the Veterans Health Administration. J Ambul Care Manage. 2001;24:68-86.
47. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37-46.
48. Steiner JF, Finn SD, Blair B, et al. Appropriate reductions in compliance among well-controlled hypertensive patients. J Clin Epidemiol. 1991; 44:1361-1371.